Similar articles for PMID: 29019447

Year	Number of Results
2001	1
2003	1
2004	1
2005	3
2006	1
2008	2
2009	6
2010	5
2011	5
2012	10
2013	7
2014	14
2015	16
2016	16
2017	27
2018	26
2019	14
2020	11
2021	11
2022	12
2023	3
2024	1

1

Survival of patients with CD20-negative variants of large B-cell lymphoma: an analysis of the National Cancer Data Base.

Qunaj L, Castillo JJ, Olszewski AJ. Qunaj L, et al. Leuk Lymphoma. 2018 Jun;59(6):1375-1383. doi: 10.1080/10428194.2017.1387912. Epub 2017 Oct 11. Leuk Lymphoma. 2018. PMID: 29019447

2

[Diffuse large B-cell lymphoma with expression of anaplastic lymphoma kinase protein: clinicopathologic and immunohistochemical study of 5 cases].

Wang WY, Ma ZG, Li GD, Liu WP, Zhong L, Wang Y, Li JM, Li L, Jiang W, Tang Y, Liao DY. Wang WY, et al. Zhonghua Bing Li Xue Za Zhi. 2006 Sep;35(9):529-34. Zhonghua Bing Li Xue Za Zhi. 2006. PMID: 17134546 Chinese.

3

Diffuse large B-cell lymphomas with plasmablastic differentiation.

Teruya-Feldstein J. Teruya-Feldstein J. Curr Oncol Rep. 2005 Sep;7(5):357-63. doi: 10.1007/s11912-005-0062-5. Curr Oncol Rep. 2005. PMID: 16091196 Review.

4

ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature.

Beltran B, Castillo J, Salas R, Quiñones P, Morales D, Hurtado F, Riva L, Winer E. Beltran B, et al. J Hematol Oncol. 2009 Feb 27;2:11. doi: 10.1186/1756-8722-2-11. J Hematol Oncol. 2009. PMID: 19250532 Free PMC article. Review.

5

Epstein-Barr Virus-Positive CD20- and CD45-Negative Diffuse Large B-Cell Lymphoma: A Diagnostic Challenge.

Starr A, Kwon DH, Kallakury B. Starr A, et al. Int J Surg Pathol. 2019 Feb;27(1):98-101. doi: 10.1177/1066896918784669. Epub 2018 Jul 3. Int J Surg Pathol. 2019. PMID: 29968492

6

CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic options.

Castillo JJ, Chavez JC, Hernandez-Ilizaliturri FJ, Montes-Moreno S. Castillo JJ, et al. Expert Rev Hematol. 2015 Jun;8(3):343-54. doi: 10.1586/17474086.2015.1007862. Epub 2015 Feb 1. Expert Rev Hematol. 2015. PMID: 25641215 Review.

7

De Novo Unclassifiable CD20-Negative Diffuse Large B-Cell Lymphoma: A Diagnostic and Therapeutic Challenge.

AbdullGaffar B, Seliem RM. AbdullGaffar B, et al. Int J Surg Pathol. 2018 May;26(3):266-270. doi: 10.1177/1066896917735170. Epub 2017 Oct 5. Int J Surg Pathol. 2018. PMID: 28982264

8

CD20-negative diffuse large B cell lymphoma: a comprehensive analysis of 695 cases.

Li J, Zhao S, Wang J, Chen J, Wen W, Zhang Q. Li J, et al. Tumour Biol. 2016 Mar;37(3):3619-37. doi: 10.1007/s13277-015-4205-5. Epub 2015 Oct 12. Tumour Biol. 2016. PMID: 26459310 Review.

9

Cd20 Expression and Effects on Outcome of Relapsed/ Refractory Diffuse Large B Cell Lymphoma after Treatment with Rituximab.

Rasheed AA, Samad A, Raheem A, Hirani SI, Shabbir- Moosajee M. Rasheed AA, et al. Asian Pac J Cancer Prev. 2018 Feb 26;19(2):331-335. doi: 10.22034/APJCP.2018.19.2.331. Asian Pac J Cancer Prev. 2018. PMID: 29479962 Free PMC article.

10

Survival of AIDS-related diffuse large B-cell lymphoma, Burkitt lymphoma, and plasmablastic lymphoma in the German HIV Lymphoma Cohort.

Schommers P, Hentrich M, Hoffmann C, Gillor D, Zoufaly A, Jensen B, Bogner JR, Thoden J, Wasmuth JC, Wolf T, Oette M, Müller M, Esser S, Vehreschild JJ, Fätkenheuer G, Wyen C. Schommers P, et al. Br J Haematol. 2015 Mar;168(6):806-10. doi: 10.1111/bjh.13221. Epub 2014 Nov 17. Br J Haematol. 2015. PMID: 25403997 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

160 results

Results by year